Treatment of Pulmonary Mycobacterial Infections

Medical and health annual. Chicago: Encyclopedia Britannica Inc, 1990: 354.

Centers for Disease Control. Tuberculosis, final data United States, 1986. MMWR 1988;36:817–820.

Snider DE Jr , ed. Mycobacterial diseases. Clin Chest Med 1989;10:1–467.

Murray JF . The white plague: Down and out, or up and coming? (J Burns Amberson lecture). Am Rev Respir Dis 1989;140:1788–1795.

Iseman MD , Madsen LA . Drug resistant tuberculosis. Clin Chest Med 1989;10:341–353.

Hinshaw HC , Feldman WH , Pfuetze KH . Treatment of tuberculosis with streptomycin: A summary of obser-vations on one hundred cases. JAMA 1946;132:778–782.

Mathewson HS . Quinolones: Anti-bacterial agents for respiratory diseases. Respir Care 1988;33:357–360.

Gellert M. DNA topoisomerases. Ann Rev Biochem 1981;50:879–910.

Cynamon MH , Klemens SP . New antimycobacterial agents. Clin Chest Med 1989;10:355–364.

Levy L , Shepard CC , Fasal P. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant Mycobacterium leprae. Am J Trop Med Hyg 1972;21:315–321.

O'Sullivan JF , Conalty ML , Morrison NE . Clofazimine analogues active against a clofazimine-resistant orga-nism. J Med Chem 1988;31:567–572.

Wehrli W. Rifampin: Mechanisms of action and resistance. Rev Infect Dis 1982;5 (Suppl 3):S412–S417.

Cynamon MH . Comparative in-vitro activities of MDL 473, rifampin and ansamycin against Mycobacterium intracellulare. Antimicrob Agents Chemother 1985;28:440–441.

Casal M , Gutierrez J , Gonzalez J , Ruiz P. In-vitro susceptibility of Mycobacterium tuberculosis to a new macrolide antibiotic: RU-28965. Tubercle 1987;63:141–143.

Bermudez LEM , Young LS . Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex. Anti-microb Agents Chemother 1988;32:1149–1153.

Davis CE Jr , Carpenter JL , Trevino S , Hoch J , Ognibene AJ . In-vitro susceptibility of Mycobacterium avium complex to antibacterial agents. Diagn Microbiol Infect Dis 1987;8:149–155.

Wallace RJ Jr , Swenson JM , Silcox VA , Bullen MG . Treatment of nonpul-monary infections due to Mycobac-terium fortuitum and Mycobacterium chelonei on the basis of in-vitro susceptibilities. J Infect Dis 1985;152:500–514.

Chakraborty A , Gangadharam PR , Damle P , Pratt P , Wright P , Davidson PT . Antituberculous activity of 6-cyclo-octylamino-5,8-quinoline-quinone (CQQ). Tubercle 1981;62:37–41.

Haneishi T , Nakajima M , Shiraishi A , . Antimycobacterial activities in vitro and in vivo and pharmacoki-netics of dihydromycoplanecin A. Antimicrob Agents Chemother 1988;32:110–116.